Diagnosis of subclinical central hypothyroidism in patients with hypothalamic-pituitary disease by Doppler echocardiography

European Journal of Endocrinology

Volumn 166, Issue 4, 2012, Pages 631-640

  Doin, Fabio Casanova ^a   Rosa Borges, Mariana ^a   Martins, Manoel R A ^a   Moisés, Valdir A ^a   Abucham, Julio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; CENTRAL HYPOTHYROIDISM; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DOPPLER ECHOCARDIOGRAPHY; ENDOCRINE DISEASE; FEMALE; HEART ISOVOLUMIC CONTRACTION TIME; HEART PERFORMANCE; HEART VENTRICLE EJECTION TIME; HUMAN; HYPOTHALAMIC PITUITARY DISEASE; HYPOTHYROIDISM; MALE; PATIENT ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SUBCLINICAL CENTRAL HYPOTHYROIDISM; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADULT; ASYMPTOMATIC DISEASES; CROSS-SECTIONAL STUDIES; DIAGNOSTIC TECHNIQUES, ENDOCRINE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPOTHALAMIC DISEASES; HYPOTHYROIDISM; MALE; MIDDLE AGED; PITUITARY DISEASES; ROC CURVE; THYROID HORMONES; THYROTROPIN; THYROXINE; YOUNG ADULT;

EID: 84859403304     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0907     Document Type: Article

References (38)

1. Beck-Peccoz P, Amr S, Menezes-Ferreira MM, Faglia G & Weintraub BD. Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism. Effect of treatment with thyrotropin-releasing hormone. New England Journal of Medicine 1985 312 1085-1090. (doi:10.1056/ NEJM198504253121703)
2. Oliveira JH, Persani L, Beck-Peccoz P & AbuchamJ. Investigating the paradox of hypothyroidism and increased serum thyrotropin (TSH) levels in Sheehan's syndrome: characterization of TSH carbohydrate content and bioactivity. Journal of Clinical Endocrinology and Metabolism 2001 86 1694-1699. (doi:10.1210/jc.86.4.1694)
3. Shimon I, Cohen O, Lubetsky A & Olchovsky D. Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidism. Thyroid 2002 12 823-827. (doi:10.1089/ 105072502760339406)
4. Ferretti E, Persani L, Jaffrain-Rea ML, Giambona S, Tamburrano G & Beck-Peccoz P. Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism. Journal of Clinical Endocrinology and Metabolism 1999 84 924-929. (doi:10.1210/jc.84.3.924)
5. Hartoft-Nielsen ML, Lange M, Rasmussen AK, Scherer S, Zimmermann-Belsing T & Feldt-Rasmussen U. Thyrotropin-releasing hormone stimulation test in patients with pituitary pathology. Hormone Research 2004 61 53-57. (doi:10.1159/000075239)
6. Klein I & Ojamaa K. Thyroid hormone and the cardiovascular system. New England Journal of Medicine 2001 344 501-509. (doi:10.1056/ NEJM200105103441901)
7. Amidi M, Leon DF, DeGroot WJ, Kroetz FW & Leonard JJ. Effect of the thyroid state on myocardial contractility and ventricular ejection rate in man. Circulation 1968 38 229-239. (doi:10.1161/01.CIR.38.2.229)
8. Taylor RR, Covell JW & Ross J Jr. Influence of the thyroid state on left ventricular tension-velocity relations in the intact, sedated dog. Journal of Clinical Investigation 1969 48 775-784. (doi:10.1172/JCI106035)
9. Hillis WS, Bremner WF, Lawrie TD & Thomson JA. Systolic time intervals in thyroid disease. Clinical Endocrinology 1975 4 617-624. (doi:10.1111/j.1365-2265.1975.tb01931.x)
10. Crowley WF Jr, Ridgway EC, Bough EW, Francis GS, Daniels GH, Kourides IA, Myers GS & Maloof F. Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. New England Journal of Medicine 1977 296 1-6. (doi:10.1056/NEJM197701062960101)
11. Weissler AM, Harris WS & Schoenfeld CD. Bedside technics for the evaluation of ventricular function in man. American Journal of Cardiology 1969 23 577-583. (doi:10.1016/0002-9149(69)90012-5)
12. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS & Stewart WJ. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Journal of the American Society of Echocardiography 2005 18 1440-1463. (doi:10.1016/j.echo.2005.10.005)
13. Kahaly G, Mohr-Kahaly S, Beyer J & Meyer J. Left ventricular function analyzed by Doppler and echocardiographic methods in short-term hypothyroidism. American Journal of Cardiology 1995 75 645-648. (doi:10.1016/S0002-9149(99) 80641-9)
14. Monzani F, Di Bello V, Caraccio N, Bertini A, Giorgi D, Giusti C & Ferrannini E. Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 2001 86 1110-1115. (doi:10.1210/jc.86.3. 1110)
15. Vitale G, Galderisi M, Lupoli GA, Celentano A, Pietropaolo I, Parenti N, De Divitiis O & Lupoli G. Left ventricular myocardial impairment in subclinical hypothyroidism assessed by a new ultrasound tool: pulsed tissue Doppler. Journal of Clinical Endocrinology and Metabolism 2002 87 4350-4355. (doi:10.1210/jc.2002-011764)
16. Biondi B, Palmieri EA, Lombardi G & Fazio S. Subclinical hypothyroidism and cardiac function. Thyroid 2002 12 505-510. (doi:10.1089/105072502760143890)
17. Yazici M, Gorgulu S, Sertbas Y, Erbilen E, Albayrak S, Yildiz O & Uyan C. Effects of thyroxin therapy on cardiac function in patients with subclinical hypothyroidism: index of myocardial performance in the evaluation of left ventricular function. International Journal of Cardiology 2004 95 135-143. (doi:10.1016/j.ijcard.2003.05.015)
18. Teichholz LE, Kreulen T, Herman MV & Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. American Journal of Cardiology 1976 37 7-11. (doi:10.1016/0002-9149(76)90491-4)
19. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, Tajik AJ & Seward JB. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function - a study in normals and dilated cardiomyopathy. Journal of Cardiology 1995 26 357-366. (Pubitemid 26011184)
20. Doin FL, Borges Mda R, Campos O, de Camargo Carvalho AC, de Paola AA, Paiva MG, Abucham J & Moises VA. Effect of central hypothyroidism on Doppler-derived myocardial performance index. Journal of the American Society of Echocardiography 2004 17 622-629. (doi:10.1016/j.echo.2004.03.010)
21. Lavine SJ. Effect of heart rate and preload on index of myocardial performance in the normal and abnormal left ventricle. Journal of the American Society of Echocardiography 2005 18 133-141. (doi:10.1016/j.echo.2004.08.036)
22. Klein I & Danzi S. Thyroid disease and the heart. Circulation 2007 116 1725-1735. (doi:10.1161/CIRCULATIONAHA.106.678326)
23. Buccino RA, Spann JF Jr, Pool PE, Sonnenblick EH & Braunwald E. Influence of the thyroid state on the intrinsic contractile properties and energy stores of the myocardium. Journal of Clinical Investigation 1967 46 1669-1682. (doi:10.1172/JCI105658)
24. Timsit J, Riou B, Bertherat J, Wisnewsky C, Kato NS,Weisberg AS, Lubetzki J, Lecarpentier Y, Winegrad S & Mercadier JJ. Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle. Journal of Clinical Investigation 1990 86 507-515. (doi:10.1172/JCI114737)
25. Ito H, Hiroe M, Hirata Y, Tsujino M, Adachi S, Shichiri M, Koike A, Nogami A & Marumo F. Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation 1993 87 1715-1721. (doi:10.1161/01.CIR.87.5.1715)
26. Delafontaine P. Insulin-like growth factor I and its binding proteins in the cardiovascular system. Cardiovascular Research 1995 30 825-834. (doi:10.1016/S0008-6363(95)00163-8)
27. Colao A. The GH-IGF-I axis and the cardiovascular system: clinical implications. Clinical Endocrinology 2008 69 347-358. (doi:10.1111/j.1365-2265. 2008.03292.x)
28. Maison P & Chanson P. Cardiac effects of growth hormone in adults with growth hormone deficiency: a meta-analysis. Circulation 2003 108 2648-2652. (doi:10.1161/01.CIR.0000100720.01867.1D)
29. Behan LA, Monson JP & Agha A. The interaction between growth hormone and the thyroid axis in hypopituitary patients. Clinical Endocrinology 2011 74 281-288. (doi:10.1111/j.1365-2265.2010.03815.x)
30. Portes ES, Oliveira JH, MacCagnan P & Abucham J. Changes in serum thyroid hormones levels and their mechanisms during long-term growth hormone (GH) replacement therapy in GH deficient children. Clinical Endocrinology 2000 53 183-189. (doi:10.1046/j.1365-2265.2000.01071.x)
31. Porretti S, Giavoli C, Ronchi C, Lombardi G, Zaccaria M, Valle D, Arosio M & Beck-Peccoz P. Recombinant human GH replacement therapy and thyroid function in a large group of adult GH-deficient patients: when does L-T(4) therapy become mandatory? Journal of Clinical Endocrinology and Metabolism 2002 87 2042-2045. (doi:10.1210/jc.87.5.2042)
32. Agha A, Walker D, Perry L, Drake WM, Chew SL, Jenkins PJ, Grossman AB & Monson JP. Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients. Clinical Endocrinology 2007 66 72-77. (Pubitemid 44952497)
33. Martins MR, Doin FC, Komatsu WR, Barros-Neto TL, Moises VA & Abucham J. Growth hormone replacement improves thyroxine biological effects: implications for management of central hypothyroidism. Journal of Clinical Endocrinology and Metabolism 2007 92 4144-4153. (doi:10.1210/jc.2007-0941)
34. Moller JE, Poulsen SH & Egstrup K. Effect of preload alternations on a new Doppler echocardiographic index of combined systolic and diastolic performance. Journal of the American Society of Echocardiography 1999 12 1065-1072. (doi:10.1016/S0894-7317(99)70103-3)
35. Spencer KT, Kirkpatrick JN, Mor-Avi V, Decara JM & Lang RM. Age dependency of the Tei index of myocardial performance. Journal of the American Society of Echocardiography 2004 17 350-352. (doi:10.1016/j.echo.2004.01.003)
36. Rosen T & Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990 336 285-288. (doi:10.1016/0140-6736(90) 91812-O)
37. Sherlock M, Ayuk J, Tomlinson JW, Toogood AA, Aragon-Alonso A, Sheppard MC, Bates AS & Stewart PM. Mortality in patients with pituitary disease. Endocrine Reviews 2010 31 301-342. (doi:10.1210/er.2009-0033)
38. Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S,Walsh JP, Asvold BO, Iervasi G, Imaizumi M, Collet TH, Bremner A, Maisonneuve P, Sgarbi JA, Khaw KT, Vanderpump MP, Newman AB, Cornuz J, Franklyn JA, Westendorp RG, Vittinghoff E & Gussekloo J. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. Journal of the American Medical Association 2010 304 1365-1374. (doi:10.1001/jama.2010.1361)